V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20213726 | 20129471 | 1.5 | 107 | Adjuvant (A) | 2020-04-12 | 2020-05-15 | EOX | 02 | N | TRIAL | 101171280 |
| 20213727 | 20129472 | 1.78 | 75.5 | Palliative (P) | 2016-08-24 | 2016-08-24 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 100866031 |
| 20213728 | 20129473 | 1.66 | 43 | Palliative (P) | 2021-04-19 | 2021-04-19 | EOX | N | null | EOX | 100849181 |
| 20213729 | 20129474 | 1.72 | 71.4 | Palliative (P) | 2017-03-08 | 2017-03-12 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100043133 |
| 20213733 | 20129475 | 0 | 107.5 | Adjuvant (A) | 2017-09-20 | 2017-09-20 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100295341 |
| 20213734 | 20129476 | 1.75 | 87.8 | Palliative (P) | 2021-02-05 | 2021-02-12 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101426541 |
| 20213738 | 20129477 | 1.58 | 67 | Disease modification (D) | 2019-09-19 | 2019-12-14 | GO2 TRIAL | 99 | Y | TRIAL | 101852020 |
| 20213739 | 20129478 | null | 76.6 | null | 2017-10-02 | 2017-10-02 | Capecitabine 35days + RT | 02 | null | CAPECITABINE + RT | 100943823 |
| 20213742 | 20129479 | 1.78 | 81.1 | Adjuvant (A) | 2019-12-15 | 2019-12-15 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 101220896 |
| 20213746 | 20129480 | 1.43 | 66.95 | Adjuvant (A) | null | 2020-01-06 | Capecitabine 35days + RT | 2 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100775238 |
| 20213748 | 20129481 | 1.58 | 115.9 | Adjuvant (A) | 2017-11-22 | 2019-07-06 | EOX | 01 | N | CETUXIMAB + IRINOTECAN + MDG | 101130980 |
| 20213750 | 20129482 | 1.67 | 79 | Palliative (P) | 2018-06-23 | 2018-07-13 | Sorafenib | 02 | N | SORAFENIB | 100043465 |
| 20213751 | 20129483 | 1.81 | 75.5 | Palliative (P) | 2019-04-02 | 2019-04-02 | EOX | 02 | N | EOX | 101857930 |
| 20213752 | 20129484 | 1.83 | 64.5 | Palliative (P) | 2021-01-05 | 2021-01-13 | Oxaliplatin + Raltitrexed | 02 | N | EOX | 100894120 |
| 20213755 | 20129485 | 1.7 | 52.2 | Palliative (P) | 2019-04-09 | 2019-04-09 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100073544 |
| 20213756 | 20129486 | 1.72 | 75.2 | Adjuvant (A) | 2020-03-28 | 2020-04-21 | EOX | 02 | N | EOX | 100578650 |
| 20213757 | 20129487 | 1.72 | 56.3 | Palliative (P) | 2018-05-13 | 2018-05-25 | Capecitabine 35days + RT | 02 | N | CAPECITABINE + RT | 101161784 |
| 20213758 | 20129488 | 1.81 | 92.3 | Palliative (P) | null | 2019-02-19 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101145204 |
| 20213759 | 20129489 | 1.81 | 69.5 | Adjuvant (A) | 2019-08-14 | 2019-08-15 | EOX | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 100946885 |
| 20213761 | 20129490 | 1.87 | 75 | Palliative (P) | 2016-07-14 | 2016-07-22 | EOX | 02 | Y | CAPECITABINE + RT | 100948937 |
| 20213763 | 20129491 | 1.59 | 68.6 | Palliative (P) | 2018-07-30 | 2018-08-06 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 101550487 |
| 20213766 | 20129492 | 1.82 | 79.4 | null | 2020-05-27 | 2020-06-16 | EOX | N | null | TRIAL | 100201202 |
| 20213767 | 20129493 | null | null | Adjuvant (A) | 2016-02-03 | 2016-02-03 | EOX | 99 | N | TRIAL | 100552850 |
| 20213768 | 20129494 | 1.74 | 86 | Palliative (P) | 2017-03-10 | 2017-03-26 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100498027 |
| 20213770 | 20129495 | 1.83 | 49.6 | Palliative (P) | 2020-03-19 | 2020-03-22 | CAPECITABINE + RT | 02 | Y | CAPECITABINE + RT | 100695308 |
| 20213772 | 20129496 | null | null | Adjuvant (A) | 2017-08-24 | 2017-08-30 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101779967 |
| 20213774 | 20129497 | 1.63 | 0 | Palliative (P) | 2021-12-31 | 2022-01-14 | Trial Unspecified | 02 | null | EOX | 100904765 |
| 20213779 | 20129498 | 1.66 | 49.2 | Neo-adjuvant (N) | 2016-09-09 | 2016-10-05 | Capecitabine 35days + RT | N | Y | CAPECITABINE + RT | 101689906 |
| 20213782 | 20129499 | 1.78 | 51.9 | null | 2017-10-19 | 2017-10-31 | EOX | 02 | null | CAPECITABINE + RT | 101348188 |
| 20213783 | 20129500 | 1.86 | 70.2 | Adjuvant (A) | 2019-05-13 | 2019-05-23 | EOX | N | N | EOX | 101190746 |
| 20213785 | 20129501 | 1.79 | 40.4 | Adjuvant (A) | 2018-06-24 | 2018-08-03 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101160806 |
| 20213788 | 20129502 | 1.88 | 58.8 | Adjuvant (A) | 2019-05-20 | 2019-05-24 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100125652 |
| 20213792 | 20129503 | 1.78 | 108.8 | Curative (C) | 2015-05-20 | 2016-11-08 | EOX | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101371701 |
| 20213794 | 20129504 | 1.81 | 86.4 | Adjuvant (A) | 2017-12-07 | 2017-12-11 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100369178 |
| 20213795 | 20129505 | 1.86 | 92.7 | Palliative (P) | 2017-10-21 | 2017-12-28 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100584143 |
| 20213796 | 20129506 | 1.67 | 76.7 | Neo-adjuvant (N) | null | 2016-08-08 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + IRINOTECAN + MDG | 101041196 |
| 20213797 | 20129507 | 1.49 | 70 | Palliative (P) | 2018-01-14 | 2018-01-14 | Sorafenib | 02 | N | SORAFENIB | 101831402 |
| 20213799 | 20129508 | 1.57 | 86.6 | null | 2017-03-30 | 2017-04-01 | Sorafenib | 99 | N | SORAFENIB | 100231045 |
| 20213800 | 20129509 | 1.7 | 66 | Palliative (P) | 2019-09-02 | 2019-10-21 | Capecitabine 35days + RT | 02 | N | CAPECITABINE + RT | 101226477 |
| 20213801 | 20129510 | 1.69 | null | Neo-adjuvant (N) | 2017-11-26 | 2017-11-29 | Sorafenib | 02 | Y | SORAFENIB | 100269055 |
| 20213802 | 20129511 | 1.66 | 59.2 | Palliative (P) | 2021-04-23 | 2021-05-14 | EOX | 02 | null | CAPECITABINE + RT | 100049754 |
| 20213803 | 20129512 | 1.63 | 46.5 | Neo-adjuvant (N) | 2017-08-07 | 2017-09-24 | EOX | 02 | N | EOX | 100426993 |
| 20213804 | 20129513 | 1.75 | 79.8 | Palliative (P) | 2017-10-16 | 2017-10-19 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100374180 |
| 20213805 | 20129514 | 1.63 | 15.6 | Curative (C) | 2017-06-17 | 2017-06-17 | EOX | N | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101640304 |
| 20213807 | 20129515 | 1.74 | 75.5 | Palliative (P) | 2017-03-12 | 2017-03-26 | Trial Unspecified | N | N | CETUXIMAB + IRINOTECAN + MDG | 101732783 |
| 20213809 | 20129516 | 2 | 78.3 | Neo-adjuvant (N) | 2019-06-19 | 2019-11-09 | Sorafenib | 02 | N | SORAFENIB | 100273193 |
| 20213810 | 20129517 | 1.59 | null | Palliative (P) | 2017-03-16 | 2017-03-23 | Oxaliplatin + Raltitrexed | Y | null | OXALIPLATIN + RALTITREXED | 100740709 |
| 20213811 | 20129518 | 1.6 | 66 | null | 2017-03-08 | 2017-04-05 | EOX | 02 | null | OXALIPLATIN + RALTITREXED | 100899857 |
| 20213813 | 20129519 | 1.58 | 59.9 | Curative (C) | 2018-05-16 | 2018-09-06 | EOX | 02 | Y | OXALIPLATIN + RALTITREXED | 101273695 |
| 20213814 | 20129520 | 1.57 | 78.5 | Palliative (P) | 2018-06-06 | 2018-06-13 | EOX | 01 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100681442 |